All Andrew Dillon articles – Page 4
-
News
In the beginning
Managers flocked to NICE's annual conference to discuss - among other things - the reinvention of the wheel.Paul Smith and Maura Thompson report
-
News
NICE goes ahead with advisory 'citizens council'
A new 'citizens council' is being set up to offer advice to the National Institute for Clinical Excellence.
-
News
Quietly does it
The NAPC annual conference was a politically subdued affair this year. Everybody happy, then - or just too busy getting on with the job? Paul Stephenson reports
-
News
A dose of scepticism
As pressure groups, drug companies and others express their doubts about the National Institute for Clinical Excellence, Lynn Eaton meets its beleaguered chief executive
-
News
Denham refers new round of cancer drugs to NICE
The National Institute for Clinical Excellence is to rule on whether a range of anti-cancer drugs should be available on the NHS. Health minister John Denham has referred a series of treatments to NICE, in a two-year programme. The list covers therapies for lung, colorectal, blood, breast, ovarian, brain and ...
-
News
NICE makes 10-year ruling on hips
The National Institute for Clinical Excellence has issued guidance on hip replacements, recommending that artificial joints should last at least 10 years in 90 per cent of cases.
-
News
Toeing the line
'Treatment for those who will benefit' was Alan Milburn's spin on the r-word at NICE's first conference. Kaye McIntosh joined the queues
-
News
Relenza verdict forces 'fasttrack' re-think
The National Institute for Clinical Excellence is to review its fast-track appraisal procedure following outgoing health secretary Frank Dobson's decision to reject Relenza for NHS prescription this winter.